Evidence map›Paper›PMID 40886507›Full record

ArticleJournal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)2025

Exposure to low levels of hexavalent chromium in drinking water alters diet-induced steatotic liver disease in male rats.

Gabrielle Griffin, Morgan E Delnicki, Haiyan Lu, Idoia Meaza, Aggie Williams, Samuel T Vielee, Oluwanifemi Esther Bolatimi, Rachel M Wise, Rui Liu, J Calvin Kouokam and 5 more

Abstract read
In one paragraph

Article in Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Gabrielle GriffinDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Morgan E DelnickiDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Haiyan LuDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Idoia MeazaDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Aggie WilliamsDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Samuel T VieleeDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Pediatrics Research Institute, Department of Pediatrics, University of Louisville, United States.
Oluwanifemi Esther BolatimiDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Rachel M WiseWise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Department of Pharmaceutical Sciences, University of New Mexico, Albuquerque, NM, United States.
Rui LiuCenter for Metals in Biology & Medicine, University of New Mexico, Albuquerque, NM, United States.
J Calvin KouokamDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Sandra S WiseDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
John Pierce WiseDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.
Matthew C CaveDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, United States.
John P WiseDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Pediatrics Research Institute, Department of Pediatrics, University of Louisville, United States.
Jamie Lynn WiseDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States; Wise Laboratory of Environmental and Genetic Toxicology, Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, United States.

Funding

University of New Mexico Center for Metals in Biology and Medicine - equipment supplementP20GM130422 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Priscilla Marie De La Cruz · 2020 to 2026
$20.4M
University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI J CHRISTOPHER STATES · 2020 to 2026
$10.0M
UOFL ENVIRONMENTAL HEALTH SCIENCES TRAINING PROGRAMT32ES011564 · NIEHS · UNIVERSITY OF LOUISVILLE · PI David W Hein, John Pierce Wise · 2004 to 2026
$7.1M
Chromosome Instability Drives Metal-Induced Lung CancerR35ES032876 · NIEHS · UNIVERSITY OF LOUISVILLE · PI John Pierce Wise · 2021 to 2026
$6.1M
Environmental Liver DiseaseR35ES028373 · NIEHS · UNIVERSITY OF LOUISVILLE · PI CAVE, MATTHEW C · 2017 to 2024
$4.0M
Cr(VI)-Induced DNA Damage Contributes to Brain AgingR21ES033327 · NIEHS · UNIVERSITY OF LOUISVILLE · PI WISE, JOHN PIERCE · 2021 to 2022
$430k
NIEHS NIH HHS P30 ES030283NIEHS NIH HHS R21 ES033327NIEHS NIH HHS R35 ES028373NIEHS NIH HHS R35 ES032876NIEHS NIH HHS T32 ES011564NIGMS NIH HHS P20 GM130422
6 · The paper itself

Abstract

Ranked as a "top 10 cause of death", chronic liver disease accounts for millions of deaths annually. The prevalence of the most prominent liver disease, metabolic dysfunction-associated steatotic liver disease (MASLD), has doubled over the past 20 years and continues to rise. Growing in parallel are environmental chemical exposures, emergingas key risk factors for liver disease. Hexavalent chromium [Cr(VI)] is the #1 chemical hazard in U.S. drinking water and is associated with increased liver disease incidence, including liver cancer. How Cr(VI) contributes to liver disease is poorly understood and no studies have considered whether Cr(VI) exposure together with high-fat diet, a well-established MASLD risk factor, drives liver disease. Thus, we developed an in vivo model to study the impact of Cr(VI) and high-fat diet on MASLD. Male Sprague Dawley rats were exposed to Cr(VI) in drinking water (0, 0.05, or 0.1 mg/L - levels that reflect the World Health Organization and U.S. Environmental Protection Agency maximum contaminant levels, respectively) and fed a normal or high-fat diet for 90 days. We observed high-fat diet significantly increased body mass, plasma lipoproteins and cholesterol, liver injury and hepatic triglycerides in rats and these outcomes were exacerbated by exposure to Cr(VI). Cr(VI) alone increased hepatic expression of alpha fetoprotein, a liver cancer biomarker, with evidence suggesting Cr(VI) and high-fat diet together increased these levels more than either exposure alone. Our results indicate Cr(VI) at very low levels combined with high-fat diet worsens liver disease, emphasizing the need to reconsider current Cr(VI) drinking water regulations.

Indexed as

ChromiumDiet, High-FatDrinking WaterFatty LiverAnimalsLiverMaleRatsRats, Sprague-DawleyChromiumchromium hexavalent ionDrinking WaterDrinking waterHexavalent chromiumLiverMale ratsMetabolic syndromeSteatosis

Identifiers

PMID40886507
PMCPMC12443201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.